Please select your view
Associate Professor Mirette Saad is a Consultant Chemical Pathologist and the National Director of Molecular Genetics at Australian Clinical Labs. At Clinical Labs, A/Prof Mirette Saad leads the Molecular Genetic testing for non-invasive prenatal testing (NIPT), antenatal screening, personalised drug therapy and cancer. She is a Chair of the RCPA Chemical Pathology Advisory Committee, Member of the RCPA Genetic Advisory Committee, AACB and a Chair of the Precision Medicine Services at Australian Clinical Labs.
Dr Deam graduated with Honours in Medicine from Monash University in 1978 and obtained his FRCPA in 1985 following postgraduate training in Biochemistry at the Royal Melbourne Hospital.
After several posts in Chemical Pathology at the Royal Melbourne Hospital and the Royal Women's Hospital, he was appointed Head of Chemical Pathology at the Royal Melbourne in 1996. He joined Gribbles Pathology (now Australian Clinical Labs) in 1998.
Dr Deam has played an active role in teaching scientific, nursing and medical staff at both undergraduate and postgraduate levels and has been an examiner for the Australasian Association of Clinical Biochemists as well as the Royal College of Pathologists of Australasia.
Dr Deam’s research interests and publications include work on thyroid function testing, various aspects of diagnostic protein measurement and the rational use of biochemical tests. His special interests include testing of endocrine function; protein abnormalities; as well as laboratory automation and application of computing to pathology services.
Associate Professor Chris Barnes is the National Director of Haematology and provides strategic direction nationally for haematology at Clinical Labs. He is a clinical and laboratory trained haematologist who has been part of Melbourne Haematology and has worked with Clinical Labs (and previously Healthscope) for several years. A/Prof Barnes also works at the Royal Children’s Hospital and is director of the Haemophilia Treatment Centre. He has experience in both management and leadership positions. A/Prof Barnes has an active clinical research interest and is also director of Melbourne Haematology (Clinical) and Melbourne Paediatric Specialists.
Dr Tony Mak is a chemical pathologist who graduated from the medical school of the Chinese University of Hong Kong. Before migrating to Australia, Tony worked as a consultant chemical pathologist at Princess Margaret Hospital – a major acute district general hospital in Hong Kong.
Tony founded, developed, and operated the highest level clinical toxicology laboratory in Hong Kong. He led his team to develop numerous useful analyses to solve many difficult clinical toxicology problems with public health implications, including Chinese medicine related poisoning, plant-related poisoning, novel psychoactive substances, slimming agents and related problems, drug alteration and counterfeit drugs.
Tony held numerous management roles in Hong Kong including Head of the Department of Pathology, Service Director (Quality and Safety) and Deputy Hospital Chief Executive. He has published more than 100 articles in international peer-reviewed academic journals and a number of books.
We are excited to announce Tony’s new role as Clinical Director, Chemical Pathology for Clinical Labs in WA.
Dr. Joel Pinczewski obtained a PhD in virology from Monash University. Soon after he moved to the United States where he completed his postdoctoral training at the National Institutes of Health. Dr Pinczewski subsequently completed medical school at the Saba University School of Medicine and a residency in Anatomical and Clinical Pathology at the University of Maryland. He then completed a dermatopathology fellowship at the University of Virginia where he trained with two of the leading dermatopathologists in the United States.
Dr Pinczewski is certified in Anatomic, Clinical and Dermatopathology by the American Board of Pathology. He is also a fellow of the Royal College of Pathologists of Australasia (FRCPA).
Dr. Pinczewski has published numerous articles in the medical literature. He is a passionate teacher and researcher and has delivered lectures in dermatopathology both nationally and internationally. Dr. Pinczewski is skilled in all areas of dermatopathology. His particular interests include melanocytic lesions, adnexal tumours and inflammatory lesions.
ACL today announced that it had entered into a binding agreement to purchase Medlab Pathology (Medlab).
Due to an increase in demand for asymptomatic testing across Australia, Clinical Labs is pleased to offer tailored packages for organisations seeking to test their staff for COVID-19.
During the COVID-19 pandemic, temporary changes to the recommended process of diagnostic testing for GDM during pregnancy and for postnatal testing in women who have had GDM may be required. Local health care institutions should make the decision about the appropriate GDM testing protocol for their local population based on demographic factors and local public health data regarding the risk of COVID-19 exposure.
Information for doctors on Telehealth Consultations including our electronic pathology request form